Revision history of "Genomic analysis of the Family Pancreatic Cancer Registry, with special attention to the basal phenotype. Screening and validation of biomarkers by liquid biopsy." (Q3152735)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

11 October 2024

  • curprev 09:2109:21, 11 October 2024DG Regio talk contribs 83,582 bytes +4 Changed label, description and/or aliases in pt
  • curprev 09:2109:21, 11 October 2024DG Regio talk contribs 83,578 bytes +14 Set a claim value: summary (P836): Em 2030, o adenocarcinoma pancreático exócrino (PDAC) será a segunda principal causa de morte por cancro, a seguir ao cancro do pulmão. 80-85 % dos doentes são diagnosticados com doença avançada. A sobrevivência aos 5 e 10 anos é de 7 % e 5 %, respetivamente. A detecção precoce durante uma fase potencialmente curável pode ser fundamental para melhorar a sobrevivência. Em 2009, estabelecemos o Registro Nacional de Cancro do Pâncreas Familiar (PANGENF...

22 March 2024

20 December 2023

12 June 2023

10 June 2023

17 August 2022

  • curprev 22:5422:54, 17 August 2022DG Regio talk contribs 82,292 bytes +57,185 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

2 December 2021

  • curprev 16:5816:58, 2 December 2021DG Regio talk contribs 16,218 bytes +2,824 Created claim: summary (P836): En 2030, l’adénocarcinome pancréatique exocrine (PDAC) sera la deuxième cause de décès par cancer après le cancer du poumon. 80-85 % des patients sont diagnostiqués avec une maladie avancée. La survie à 5 ans et à 10 ans est de 7 % et 5 % respectivement. La détection précoce à un stade potentiellement guérissable peut être essentielle à l’amélioration de la survie. En 2009, nous avons créé le Registre national du cancer pancréatique familial (PA...
  • curprev 16:5816:58, 2 December 2021DG Regio talk contribs 13,394 bytes +241 Changed label, description and/or aliases in fr: translated_label

12 October 2021

  • curprev 15:4015:40, 12 October 2021DG Regio talk contribs 13,153 bytes +222 Changed label, description and/or aliases in en: translated_label
  • curprev 15:4015:40, 12 October 2021DG Regio talk contribs 12,931 bytes +2,531 Created claim: summary (P836): In 2030 exocrine pancreatic adenocarcinoma (PDAC) will be the second leading cause of cancer death after lung cancer. 80-85 % of patients are diagnosed with advanced disease. Survival at 5 and 10 years is 7 % and 5 %, respectively. Early detection during a potentially curable stage can be key to improving survival. In 2009, we established the National Register of Family Pancreatic Cancer (PANGENFAM) to identify and characterise high-risk familie...

10 October 2021

9 October 2021

8 October 2021